BiotechTube
Home/Op2Lysis/Kathy Van Butsele
KV

Kathy Van Butsele

Ph.D., Regulatory Affairs - CMC

Op2Lysis

Therapeutic Areas

Hemorrhagic StrokeCerebrovascular Disease

Op2Lysis Pipeline

DrugIndicationPhase
O2L-001Hemorrhagic Stroke (Intracerebral Hemorrhage)Pre-clinical

Leadership Team at Op2Lysis

CG
Christophe Gaudin
CEO & Co-founder
JP
Jérôme Parcq
CSO & Co-founder
SP
Solène Palmieri
Pharm.D. & Toxicologist, Regulatory Affairs - non clinical development
AT
Audrey Thiebaut
Ph.D., R&D project manager
View full Op2Lysis profile